


Pharmaceuticals & Biotechnology | Small Cap
Aarti Pharmalabs Ltd demonstrates a mixed financial performance. The company shows excellent solvency, growth, coverage, and profitability, indicating a strong ability to meet long-term obligations, expand its operations, cover its financial obligations, and generate profits. Its financial ratios are also strong, driven by high adjusted and cash earnings per share and book value. However, the company's liquidity and efficiency ratios suggest some challenges in managing short-term obligations and utilizing assets effectively. While revenue and profit growth are robust, the company needs to focus on improving its working capital management and asset turnover to achieve a more balanced financial profile. Capital expenditure is a concern. Overall, Aarti Pharmalabs exhibits solid financial health with potential for further improvement in specific areas.
Aarti Pharmalabs Ltd demonstrates a mixed financial performance. The company shows excellent solvency, growth, coverage, and profitability, indicating a strong ability to meet long-term obligations, expand its operations, cover its financial obligations, and generate profits. Its financial ratios are also strong, driven by high adjusted and cash earnings per share and book value. However, the company's liquidity and efficiency ratios suggest some challenges in managing short-term obligations and utilizing assets effectively. While revenue and profit growth are robust, the company needs to focus on improving its working capital management and asset turnover to achieve a more balanced financial profile. Capital expenditure is a concern. Overall, Aarti Pharmalabs exhibits solid financial health with potential for further improvement in specific areas.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
35.61
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
35.92
P/B RATIO
2.96
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
3.29
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
16.23
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹692.25 as on Aug 6, 2026.
The company exhibits excellent growth across various metrics, including revenue, operating profit, EPS, assets, and net income. This indicates a strong upward trajectory and effective growth strategies. The company's consistent growth positions it well for future success and market leadership.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 62.08 | -4.73 | 14.14 | -14 | |
| Operating Profit Growth Rate | 65.22 | 12.87 | 20.21 | -20.47 | |
| Earnings Per Share (EPS) Growth | 12.08 | 25.57 | -35.87 | ||
| Asset Growth Rate | 10 | 15.06 | 12.55 | 19.82 | |
| Net Income Growth Rate | 58.2 | 12.44 | 25.35 | -35.66 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | FDC Ltd | 7.64 | 21.40 | Neutral | 346.00 | 17.56 | 281.00 |
| 2 | Supriya Lifescience Ltd | 7.46 | 34.29 | Highly Overvalued | 294.00 | 25.98 | 209.00 |
| 3 | Aarti Pharmalabs Ltd | 7.46 | 35.92 | Neutral | 369.00 | 19.43 | 175.00 |
| 4 | Innova Captab Ltd | 7.36 | 38.74 | Overvalued | 243.00 | 14.63 | 141.00 |
| 5 | Akums Drugs & Pharmaceuticals Ltd | 7.28 | 40.87 | Overvalued | 522.00 | 7.09 | 256.00 |
| 6 | Marksans Pharma Ltd | 7.24 | 29.16 | Neutral | 601.00 | 6.64 | 420.00 |
| 7 | Aarti Drugs Ltd | 7.20 | 19.23 | Undervalued | 309.00 | 18.54 | 195.00 |
| 8 | Hikal Ltd | 7.13 | -55.92 | Neutral | 220.00 | -3.95 | -49.00 |
| 9 | RPG Life Sciences Ltd | 7.12 | 38.61 | Neutral | 147.00 | 69.64 | 115.00 |
| 10 | Alembic Ltd | 7.06 | 7.01 | Undervalued | 90.00 | 4.85 | 317.00 |
| 11 | SMS Pharmaceuticals Ltd | 5.94 | 32.80 | Neutral | 171.00 | 9.35 | 102.00 |
| 12 | Shilpa Medicare Ltd | 5.94 | 59.39 | Highly Overvalued | 435.00 | 6.80 | 243.00 |
| 13 | Strides Pharma Science Ltd | 5.55 | 16.53 | Undervalued | 925.00 | 19.92 | 575.00 |
| 14 | Jeena Sikho Lifecare Ltd | 5.52 | 33.85 | Neutral | 349.00 | 17.87 | 222.00 |
| 15 | Gufic BioSciences Ltd | 5.49 | 63.18 | Neutral | 151.00 | 6.30 | 64.00 |
| 16 | Dishman Carbogen Amcis Ltd | 5.38 | 31.30 | Neutral | 566.00 | -2.45 | 97.00 |
| 17 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 34.79 | Undervalued | 269.00 | 4.69 | 138.00 |
| 18 | Orchid Pharma Ltd | 4.85 | 246.31 | Neutral | 41.00 | 8.91 | 21.00 |
| 19 | Sequent Scientific Ltd | 4.61 | 313.39 | Overvalued | 162.00 | 1.74 | 32.00 |
| 20 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.53 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 21 | Zota Health Care Ltd | 3.97 | -58.38 | Neutral | 19.00 | 8.06 | -74.00 |
| 22 | Procter & Gamble Health Ltd | 3.45 | 30.81 | Neutral | 457.00 | 196.94 | 327.00 |
| 23 | Sanofi India Ltd | 3.45 | 18.66 | Neutral | 491.00 | 134.52 | 413.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral